Bioventus, Inc. (BVS)
8.97
-0.18
(-1.97%)
USD |
NASDAQ |
Apr 02, 16:00
8.955
-0.02
(-0.17%)
After-Hours: 20:00
Bioventus Total Assets (Quarterly) : 683.56M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Abbott Laboratories | 86.71B |
| Accuray, Inc. | 448.01M |
| Alphatec Holdings, Inc. | 791.21M |
| Boston Scientific Corp. | 43.67B |
| Plus Therapeutics, Inc. | 16.32M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 455.11M |
| Shareholders Equity (Quarterly) | 184.10M |
| Debt to Equity Ratio | 1.691 |
| Current Ratio | 1.701 |
| Net Debt Paydown Yield | 3.33% |